Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Robert Modigliani"'
Autor:
Alain Aubert, Pascal Hammel, Jean-Marc Gornet, Robert Modigliani, Marc Lémann, Philippe Ruszniewski, Dermot O'Toole, Philippe Lévy
Publikováno v:
Gastroentérologie Clinique et Biologique. 31:303-306
Resume L’infiltration graisseuse diffuse et primitive du pancreas est une cause rare d’insuffisance pancreatique exocrine chez l’adulte. Nous rapportons deux observations de malades ayant une diarrhee chronique avec steatorrhee chez lesquels le
Autor:
Robert Modigliani, Pierre Cattan, Philippe Bertheau, Göran Granerus, Marc Lémann, Jean-Didier Rain, Sven Almer, Joëlle Bonnet, Lennart Franzén, Gunnar Olaison, Magnus Ström, K. Smedh
Publikováno v:
Inflammatory Bowel Diseases. 13:164-174
Leukocyte scintigraphy is a noninvasive investigation to assess inflammation. We evaluated the utility of labeled leukocytes to detect small bowel inflammation and disease complications in Crohn's disease and compared it to whole small bowel enterosc
Autor:
Jean-Frederic Colombel, Robert Modigliani, Marc Lémann, Jean-Yves Mary, Jean-Louis Dupas, Yann Consigny
Publikováno v:
Inflammatory Bowel Diseases. 12:551-557
Background In Crohn's disease, studies have evaluated the ability of biological markers to predict relapse in the next 12 to 18 months, without differentiating early from late relapses. The aim of this study was to look for biological markers of shor
Autor:
K. Vahedi, Robert Modigliani, Yoram Bouhnik, J. Villarejo, Matthieu Allez, Jean-Marc Sabate, Marc Lémann, Jean-Marc Gornet
Publikováno v:
Alimentary Pharmacology & Therapeutics. 18:409-413
Aim To evaluate the safety and long-term efficacy of per-endoscopic hydrostatic balloon dilatation in a retrospective series of patients with Crohn's disease. Methods Thirty-eight patients had balloon dilatation for intestinal symptomatic strictures
Autor:
Jean-Marc Victor, Steen Christensen, Curt Tysk, Sven Almer, Jean-Pierre Hugot, Jean-Frederic Colombel, Robert Modigliani, Jacques Belaiche, Gilles Thomas, J. Macry, Corinne Gower-Rousseau, Jean-Pierre Cézard, Sean Montague, Yigael Finkel, Suzanne Lesage, Mathias Chamaillard, Miquel A. Gassull, Habib Zouali
Publikováno v:
European Journal of Human Genetics. 11:179-184
Crohn's disease (CD) is a complex genetic disorder for which aetiology is unknown. Recently, genetic factors for susceptibility have been described. Several genetic loci have been mapped and partially explain the familial aggregations of the disease.
Autor:
Robert Modigliani, J. Villarejo, Jean-Marc Sabate, Matthieu Allez, Joëlle Bonnet, Marc Lémann
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:1117-1124
Summary Background : Infliximab, a chimeric monoclonal antibody to tumour necrosis factor-α, is a new potent therapy for active Crohn's disease, but induces short-lived improvements. Aim : To evaluate the efficacy of thalidomide, a drug with anti-tu
Publikováno v:
The American Journal of Gastroenterology. 97:947-953
OBJECTIVE: Prediction of the clinical course of Crohn’s disease (CD) is difficult in the long term. Our aim was to determine whether the presence of severe endoscopic lesions (SELs) may predict a higher risk of colectomy and penetrating complicatio
Autor:
Mathias Chamaillard, Gilles Thomas, Yigael Finkel, Habib Zouali, Antoine Cortot, Pierre Laurent-Puig, Curt Tysk, Robert Modigliani, Suzanne Lesage, Sven Almer, Mourad Sahbatou, Jean-Pierre Cézard, Jacques Belaiche, Vibeke Binder, J. Macry, Colm O'Morain, Miquel A. Gassull, Jean-Frederic Colombel, C. Gower-Rousseau, Jean-Pierre Hugot
Publikováno v:
Nature. 411:599-603
Crohn's disease and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped to chromosome 16. Here we have used a pos
Autor:
Cosimo Prantera, Richard N. Fedorak, Morten H. Vatn, Frank Seibold, D S Rampton, R. A. van Hogezand, Stefan Schreiber, Paul Rutgeerts, Martin Zeitz, S. J. H. Van Deventer, Alastair Forbes, Robert Löfberg, W Petritsch, Jean-Frederic Colombel, Miquel A. Gassull, Jean-Pierre Gendre, B Feagan, Robert Modigliani, Francesco Pallone, Massimo Campieri
Publikováno v:
International Journal of Colorectal Disease. 16:1-11
The introduction of novel anti-tumor necrosis factor (TNF) agents has not only led to impressive new therapeutic opportunities but also resulted in uncertainty regarding their optimal use and possible side effects. Guidelines are presented here for t
Autor:
Robert Modigliani
Publikováno v:
Inflammatory Bowel Diseases. 6:251-257
Immunosuppressors used in inflammatory bowel disease (IBD) are useful in refractory, chronic, active, steroid-dependent, or steroid-resistant IBD, but do not provide a permanent cure for IBD, their effect being only temporary. Only azathioprine and m